BGLC Stock Analysis: Buy, Sell, or Hold?

BGLC - BioNexus Gene Lab Corp Common stock

SERVICES-MEDICAL LABORATORIES
$1.59
0.00 (0.22%) ▲
5d: +1.27%
30d: +3.25%
90d: -21.29%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026 0d

Get Alerted When BGLC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: BGLC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: BGLC is currently trading at $1.59, which is considered slightly high relative to its 30-day fair value range of $1.43 to $1.64.

Technical Outlook: Technically, BGLC is in a strong downtrend. Immediate support is located at $1.51, while resistance sits at $1.88.

Market Sentiment: BGLC scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.43 - $1.64
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 35.3%

All Signals

  • BEARISH: Weak technical setup (38/100)
  • BULLISH: High volume confirmation
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $1.43 - $1.64
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.51
Resistance Level $1.88
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Revenue Growth (YoY) -98.9%
Earnings Growth (YoY) -95.0%
Profit Margin -54.7%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 8:00 AM ET
Data refreshes hourly during market hours. Next update: 9:00 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BGLC.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$547 67 BUY
ECL
Ecolab Inc
STRONG BUY
27 analysts
$325 48 HOLD
SHW
Sherwin-Williams Co
BUY
28 analysts
$390 43 HOLD
APD
Air Products and Chemicaâ€Ļ
BUY
24 analysts
$343 49 HOLD
DD
Dupont De Nemours Inc
STRONG BUY
16 analysts
$170 55 HOLD

More Analysis for BGLC

BGLC Technical Chart BGLC Price Prediction BGLC Earnings Date BGLC Investment Advisor BGLC Fair Price Analyzer BGLC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals